Cargando…
Metformin disrupts malignant behavior of oral squamous cell carcinoma via a novel signaling involving Late SV40 factor/Aurora-A
Conventional therapeutic processes in patient with OSCC are associated with several unfavorable effects leading to patients with poor survival rate. Metformin has been shown to protect against a variety of specific diseases, including cancer. However, the precise roles and mechanisms underlying the...
Autores principales: | Chen, Chang-Han, Tsai, Hsin-Ting, Chuang, Hui-Ching, Shiu, Li-Yen, Su, Li-Jen, Chiu, Tai-Jan, Luo, Sheng-Dean, Fang, Fu-Min, Huang, Chao-Cheng, Chien, Chih-Yen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5430965/ https://www.ncbi.nlm.nih.gov/pubmed/28465536 http://dx.doi.org/10.1038/s41598-017-01353-8 |
Ejemplares similares
-
Suppression of Aurora-A-FLJ10540 signaling axis prohibits the malignant state of head and neck cancer
por: Chen, Chang-Han, et al.
Publicado: (2015) -
Aurora-A signaling is activated in advanced stage of squamous cell carcinoma of head and neck cancer and requires osteopontin to stimulate invasive behavior
por: Chien, Chih-Yen, et al.
Publicado: (2014) -
The SV40 Late Protein VP4 Is a Viroporin that Forms Pores to Disrupt Membranes for Viral Release
por: Raghava, Smita, et al.
Publicado: (2011) -
Simian virus 40 (SV40)-transgenic mice that develop tumors are specifically tolerant to SV40 T antigen
Publicado: (1987) -
SV40 and human mesothelioma
por: Carbone, Michele, et al.
Publicado: (2020)